Changing attitudes towards non-invasive aneuploidy screening at advanced maternal age in a German tertiary care center

Ultraschall in der Medizin

Volumn 28, Issue 1, 2007, Pages 67-70

  Geipel, Annegret ^a   Daiss, T ^b   Katalinic, A ^b   Germer, U ^b   Kohl, T ^a   Krapp, M ^b   Gembruch, U ^a   Berg, C ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Advanced maternal age; Chromosomal abnormalities; First and second trimester targeted ultrasound; Genetic sonography; Invasive prenatal diagnosis; Nuchal translucency

Indexed keywords

ANEUPLOIDY; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; FEMALE; FETUS DISEASE; GERMANY; GESTATION PERIOD; HUMAN; KARYOTYPE; MATERNAL AGE; NORMAL HUMAN; TERTIARY HEALTH CARE; TRISOMY; ATTITUDE TO HEALTH; ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GENETIC DISORDER; GESTATIONAL AGE; PREGNANCY; PRENATAL DEVELOPMENT; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY;

ANEUPLOIDY; ATTITUDE TO HEALTH; FEMALE; GENETIC DISEASES, INBORN; GESTATIONAL AGE; HUMANS; MATERNAL AGE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; RETROSPECTIVE STUDIES;

EID: 34247197666     PISSN: 01724614     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858573     Document Type: Article

References (28)

1. Shohat M, Akstein E, Davidov B et al. Amniocentesis rate and the detection of Down syndrome and other chromosomal anomalies in Israel. Prenat Diagn 1995; 15: 967-970
2. Pandya PP, Goldberg H, Walton B et al. The implementation of first-trimester scanning at 10-13 weeks' gestation and the measurement of nuchal translucency thickness in two maternity units. Ultrasound Obstet Gynecol 1995; 5: 20-25
3. Yagel S, Anteby EA, Hochner-Celnikier D et al. The role of mid-trimester targeted fetal organ screening combined with the"triple test" and maternal age in the diagnosis of trisomy 21: A retrospective study. Am J Obstet Gynecol 1998; 178: 40-44
4. Wellesley D, Boyle B, Barber J et al. Retrospective audit of different antenatal screening policies for Down's syndrome in eight district general hospitals in one health region. BMJ 2002; 325: 1-5
5. Nicolaides KH. Screening for chromosomal defects. (Editorial) Ultrasound Obstet Gynecol 2003; 21: 313-321
6. Nicolaides KH, Snijders RJM, Gosden CM et al. Ultrasonographically detectable markers of fetal chromosomal abnormalities. Lancet 1992; 340: 704-707
7. Snijders RJM, Johnson S, Sebire NJ et al. First trimester ultrasound screening for chromosomal defects. Ultrasound Obstet Gynecol 1996; 7: 216-226
8. Snijders RJM, Noble P, Sebire N et al. UK multi-center project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet 1998; 352: 343-346
9. Souka AP, Snijders RJM, Novakov A et al. Defects and syndromes in chromosomally normal foetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 1998; 11: 391-400
10. Bromley B, Lieberman E, Benacerraf BR. The incorporation of maternal age into the sonographic scoring index for the detection at 14-20 weeks of foetuses with Down's syndrome. Ultrasound Obstet Gynecol 1997; 10: 321-324
11. Salihu HM, Boos R, Schmidt W. Antenatally detectable markers for the diagnosis of autosomally trisomic foetuses in at-risk pregnancies. Am J Perinatol 1997; 14: 257-261
12. DeVore GR. The genetic sonogram: its use in the detection of chromosomal abnormalities in foetuses of women of advanced maternal age. Prenat Diagn 2001; 21: 40-45
13. Shipp TD, Benacerraf BR. Second trimester ultrasound screening for chromosomal abnormalities. Prenat Diagn 2002; 22: 296-307
14. Egan JF, Malakh L, Turner GW et al. Role of ultrasound for Down syndrome screening in advanced maternal age. Am J Obstet Gynecol 2001; 185: 1028-1031
15. Pinette MG, Garrett J, Salvo A et al. Normal mid trimester (17-20 weeks) genetic sonogram decreases amniocentesis rate in a high-risk population. J Ultrasound Med 2001; 20: 639-644
16. Rosen DJ, Kedar I, Amiel A et al. A negative second trimester triple test and absence of specific ultrasonographic markers may decrease the need for genetic amniocentesis in advanced maternal age by 60%. Prenat Diagn 2002; 22: 59-63
17. Vintzileos AM, Guzman ER, Smulian JC et al. Second-trimester genetic sonography in patients with advanced maternal age and normal triple screen. Obstet Gynecol 2002; 99: 993-995
18. Vintzileos AM, Guzman ER, Smulian JC et al. Down syndrome risk estimation after normal genetic sonography. Am J Obstet Gynecol 2002; 187: 1226-1229
19. Hobbins JC, Lezotte DC, Persutte WH et al. An 8-center study to evaluate the utility of mid-term genetic sonograms among high-risk pregnancies. J Ultrasound Med 2003; 22: 33-38
20. Zoppi MA, Ibba RM, Putzolu M et al. Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in woman aged 35 years and older. Obstet Gynecol 2001; 97: 916-920
21. Gasiorek-Wiens A, Tercanli S, Kozlowski P et al. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland. Ultrasound Obstet Gynecol 2001; 18: 645-648
22. Nadel AS, Bromley B, Frigoletto FD et al. Can the presumed risk of autosomal trisomy be decreased in foetuses of older women following a normal sonogram? J Ultrasound Med 1995; 14: 297-302
23. Johnson JP, Streets K, Fitzgerald J et al. Influence of triple-marker screen risk versus a priori risk in decision for amniocentesis in women of advanced maternal age. Prenat Diagn 1998; 18: 979-986
24. Vergani P, Locatelli A, Biffi A et al. Factors affecting the decision regarding amniocentesis in women at genetic risk because of age 35 years or older. Prenat Diagn 2002; 22: 769-774
25. Yeo L, Vintzileos M. The use of genetic sonography to reduce the need for amniocentesis in women at high-risk for Down syndrome. Sem Perinatol 2003; 27: 152-159
26. Vintzileos AM, Guzman ER, Smulian JC et al. Choice of second-trimester genetic sonogram for detection of trisomy 21. Obstet Gynecol 1997; 90: 187-190
27. Bahado-Singh RO, Deren O, Oz U et al. An alternative for women initially declining genetic amniocentesis: individual Down syndrome odds on the basis of maternal age and multiple sonographic markers. Am J Obstet Gynecol 1998; 179: 514-519
28. Kocun CC, Harrigan JT, Canterino JC et al. Changing trends in patients decision concerning genetic amniocentesis. Am J Obstet Gynecol 2000; 182: 1018-1020